You are here: Industry Insights > FDA

News List

Pharmaceutical News of the Week (July. 6th-July. 10th) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 21, 2020
With the second week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week.The news involved 6 sections: approval, R&D, policies, transactions, listing and miscellany that happened during July 6-10.
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
Overseas Marketing of Fruquintinib Accelerated as It Receives the FDA’s Fast Track Designation PharmaSources/Xiaoyaowan
July 06, 2020
Hutchison MediPharma’s targeted anticancer drug: fruquintinib has recently received the Fast Track designation granted by the FDA for the treatment of patients with metastatic colorectal cancer (mCRC).
Pharmaceutical News of the Week (June.22-27) | PharmaSources.com PharmaSources/Caicai
July 01, 2020
With the last week of June coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 22-28, including 22 pieces.
Pharma and Health from Ingredients to Pills: FDA Drug Recalls 101 Lin Zhang
June 15, 2020
Pharmaceutical drug use in the USA dates back more than a century, and the use of these drugs led to creation of new acts or changes to the existing ones.
Conducting Clinical Trials amid the COVID-19 Outbreak: FDA Encourages Sponsors to Go Virtual Neeta Ratanghayra
April 08, 2020
For pharmaceutical companies, one of the most significant operational impacts of the COVID-19 is on clinical trials. On March 19, 2020, the U.S. Food and Drug Administration (FDA) issued guidance on the conduct of clinical trials during the COVID-19 pande
Polpharma Biologics Announces FDA Approval of Tyruko® - First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple Sclerosis PharmaSources
August 28, 2023
On August 25, 2023,Polpharma Biologics announced today that the U.S. Food and Drug Administration (FDA) is the first regulatory body worldwide to approve the use of Tyruko®.
FDA Inspections of Outsourcing Facilities FDA
March 31, 2022
Provide an overview of the inspection process for compounding outsourcing facilities.
Immunogenicity Information in Labeling FDA
March 25, 2022
This webinar has been approved for 1.5 contact hours of continuing education for pharmacists, physicians, and nurses. Please see detailed announcement for additional information.
FDA Approves First Generic of Symbicort to Treat Asthma and COPD FDA
March 17, 2022
Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 365 366 Next page